Lower CSF homovanillic acid levels in depressed patients with a history of alcoholism

Neuropsychopharmacology

Volumn 28, Issue 9, 2003, Pages 1712-1719

  Sher, Leo ^a   Oquendo, Maria A ^a   Li, Shuhua ^a   Huang, Yung Yu ^a   Grunebaum, Michael F ^a   Burke, Ainsley K ^a   Malone, Kevin M ^a   Mann, J John ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Alcoholism; Cerebrospinal fluid; Depression; Dopamine; Homovanillic acid

Indexed keywords

4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; 5 HYDROXYINDOLEACETIC ACID; HOMOVANILLIC ACID; MONOAMINE;

AGGRESSION; ALCOHOLISM; ANTISOCIAL BEHAVIOR; ARTICLE; BORDERLINE STATE; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CHROMATOGRAPHY; CIGARETTE SMOKING; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DELUSION; DEPRESSION; DISEASE SEVERITY; DOPAMINE BRAIN LEVEL; DOPAMINERGIC ACTIVITY; ELECTROCHEMICAL DETECTION; HIGH PERFORMANCE LIPID CHROMATOGRAPHY; HUMAN; HYPOTHESIS; IMPULSIVENESS; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; METABOLITE; MONOAMINE METABOLISM; NORADRENALIN BRAIN LEVEL; PRIORITY JOURNAL; PSYCHOMOTOR RETARDATION; REMISSION; SEROTONIN BRAIN LEVEL; SMOKING; SUICIDAL BEHAVIOR; SUICIDE ATTEMPT; ADULT; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; DEMOGRAPHY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INSTRUMENTATION; MALE; METHODOLOGY; MIDDLE AGED; PERSONALITY TEST; PUNCTURE;

ADULT; ALCOHOLISM; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEMOGRAPHY; DEPRESSIVE DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HOMOVANILLIC ACID; HUMANS; HYDROXYINDOLEACETIC ACID; MALE; METHOXYHYDROXYPHENYLGLYCOL; MIDDLE AGED; PERSONALITY INVENTORY; SPINAL PUNCTURE;

EID: 0141781029     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300231     Document Type: Article

References (113)

1. Aberg-Wistedt A, Wistedt B, Bertilsson L (1985). Higher CSF levels of HVA and 5-HIAA in delusional compared to nondelusional depression. Arch Gen Psychiatry 42: 925-926.
2. Adinoff B, Anton R, Linnoila M, Guidotti A, Nemeroff CB, Bissette G (1996). Cerebrospinal fluid concentrations of corticotropin-releasing hormone (CRH) and diazepam-binding inhibitor (DBI) during alcohol withdrawal and abstinence. Neuropsychopharmacology 15: 288-295.
3. Adinoff B, Kramer GL, Petty F (1995). Levels of gamma-aminobutyric acid in cerebrospinal fluid and plasma during alcohol withdrawal. Psychiatry Res 59: 137-144.
4. Adinoff B, Nemeroff CB, Bissette G, Martin PR, Linnoila M (1991). Inverse relationship between CSF TRH concentrations and the TSH response to TRH in abstinent alcohol-dependent patients. Am J Psychiatry 148: 1586-1588.
5. Almay BG, Haggendal J, von Knorring L, Oreland L (1987). 5-HIAA and HVA in CSF in patients with idiopathic pain disorders. Biol Psychiatry 22: 403-412.
6. American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). APA Press: Washington, DC.
7. Asberg M, Bertilsson L, Martensson B, Scalia-Tomba GP, Thoren P, Traskman-Bendz L (1984). CSF monoamine metabolites in melancholia. Acta Psychiatr Scand 69: 201-219.
8. Badawy AAB (1998). Alcohol, aggression and serotonin: metabolic aspects. Alcohol Alcoholism 33: 66-72.
9. Barratt ES (1965). Factor analysis of some psychometric measures of impulsiveness and anxiety. Psychol Rep 16: 547-554.
10. Bates ME, Labouvie EW (1995). Personality-environment constellations and alcohol use: a process-oriented study of intraindividual change during adolescence. Psychol Addict Behav 9: 23-35.
11. Beck AT, Kovacs M, Weissman A (1979). Assessment of suicidal intention: the scale for suicide ideation. J Consult Clin Psychol 47: 343-352.
12. Beck RW, Morris JB, Beck AT (1974a). Cross-validation of the suicidal intent scale. Psychol Rep 34: 445-446.
13. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961). An inventory for measuring depression. Arch Gen Psychiatry 4: 53-63.
14. Beck AT, Weissman A, Lester D, Trexler L (1974b). The measurement of pessimism: the hopelessness scale. J Consult Clin Psychol 42: 861-865.
15. Blazer DG, Kessler RC, McGonagle KA, Swartz MS (1994). The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey. Am J Psychiatry 151: 979-986.
16. Borg S, Kvande H, Rydberg U, Terenius L, Wahlstrom A (1982). Endorphin levels in human cerebrospinal fluid during alcohol intoxication and withdrawal. Psychopharmacology (Berl) 78: 101-103.
17. Bowers Jr M (1972). Clinical measurements of central dopamine and 5-hydroxytryptamine metabolism: reliability and interpretation of cerebrospinal fluid acid monoamine metabolite measures. Neuropharmacology 11: 101-111.
18. Brown AS, Gershon S (1993). Dopamine and depression. J Neural Transm Gen Sect 91: 75-109.
19. Brown GL, Goodwin FK (1986). Human aggression and suicide. Suicide Life Threat Behav 16: 223-243.
20. Buydens-Branchey L, Branchey MH, Noumair D (1989). Age of alcoholism onset. I. Relationship to psychopathology. Arch Gen Psychiatry 46: 225-230.
21. Campanella G, Algeri S, Cerletti C, Dolfini E, Jori A, Rinaldi F (1977). Correlation of clinical symptoms, HVA and 5-HIAA in csf and plasma L-DOPA in Parkinsonian patients treated with L-DOPA and L-DOPA+RO 4-4602. Eur J Clin Pharmacol 11: 255-261.
22. Caspi A, Begg D, Dickson N, Harrington H, Langley J, Moffitt TE et al (1997). Personality differences predict health-risk behaviors in young adulthood: evidence from a longitudinal study. J Pers Soc Psychol 73: 1052-1063.
23. Chotai J, Kullgren G, Asberg M (1998). CSF monoamine metabolites in relation to the diagnostic interview for borderline patients (DIB). Neuropsychobiology 38: 207-212.
24. Cloninger CR, Sigvardsson S, Bohman M (1988). Childhood personality predicts alcohol abuse in young adults. Alcohol Clin Exp Res 12: 494-505.
25. Cornelius JR, Salloum IM, Day NL, Thase ME, Mann JJ (1996). Patterns of suicidality and alcohol use in alcoholics with major depression. Alcohol Clin Exp Res 20: 1451-1455.
26. Cornelius JR, Salloum IM, Lynch K, Clark DB, Mann JJ (2001). Treating the substance-abusing suicidal patient. Ann NY Acad Sci 932: 78-90.
27. Cornelius JR, Salloum IM, Mezzich J, Cornelius MD, Fabrega Jr H, Ehler JG et al (1995). Disproportionate suicidality in patients with comorbid major depression and alcoholism. Am J Psychiatry 152: 358-364.
28. Daderman AM, Lidberg L (2002). Relapse in violent crime in relation to cerebrospinal fluid monoamine metabolites (5-HIAA, HVA and HMPG) in male forensic psychiatric patients convicted of murder: a 16-year follow-up. Acta Psychiatr Scand 106(Suppl 412): 71-74.
29. Davidson KM, Blackburn IM (1998). Co-morbid depression and drinking outcome in those with alcohol dependence. Alcohol Alcoholism 33: 482-487.
30. Diana M, Pistis M, Carboni S, Cessa GL, Rossetti ZL (1993). Profound decrement of mesolimbic dopaminergic neuronal activity during ethanol withdrawal syndrome in rats: electrophysiological and biochemical evidence. Proc Natl Acad Sci USA 90: 7966-7969.
31. Engstrom G, Alling C, Blennow K, Regnell G, Traskman-Bendz L (1999). Reduced cerebrospinal HVA concentrations and HVA/5-HIAA ratios in suicide attempters. Monoamine metabolites in 120 suicide attempters and 47 controls. Eur Neuropsychopharmacol 9: 399-405.
32. Faustman WO, King RJ, Faull KF, Moses Jr JA, Benson KL, Zarcone VP et al (1991). MMPI measures of impulsivity and depression correlate with CSF 5-HIAA and HVA in depression but not schizophrenia. J Affect Disord 22: 235-239.
33. Fils-Aime ML, Eckardt MJ, George DT, Brown GL, Mefford I, Linnoila M (1996). Early-onset alcoholics have lower cerebrospinal fluid 5-hydroxyindoleacetic acid levels than late-onset alcoholics. Arch Gen Psychiatry 53: 211-216.
34. Fromme K, D'Amico EJ (1999). Neurobiological bases of alcohol's psychological effects. In: Leonard KE, Blane HT (eds) Psychological Theories of Drinking and Alcoholism. Guilford Press: New York. pp 422-455.
35. Fujimoto A, Nagao T, Ebara T, Sato M, Otsuki S (1983). Cerebrospinal fluid monoamine metabolites during alcohol withdrawal syndrome and recovered state. Biol Psychiatry 18: 1141-1152.
36. Geracioti Jr TD (1997). Cerebrospinal fluid neuroendocrinology of alcohol misusers. Addict Biol 2: 401-409.
37. Geracioti Jr TD, Loosen PT, Ebert MH, Ekhator NN, Burns D, Nicholson WE et al (1994). Concentrations of corticotropin-releasing hormone, norepinephrine, MHPG, 5-hydroxyindoleacetic acid, and tryptophan in the cerebrospinal fluid of alcoholic patients: serial sampling studies. Neuroendocrinology 60: 635-642.
38. Geracioti Jr TD, Nicholson WE, Orth DN, Ekhator NN, Loosen PT (1993). Cholecystokinin in human cerebrospinal fluid: concentrations, dynamics, molecular forms and relationship to fasting and feeding in health, depression and alcoholism. Brain Res 629: 260-268.
39. Geracioti Jr TD, West SA, Baker DG, Hill KK, Ekhator NN, Wortman MD et al (1999). Low CSF concentration of a dopamine metabolite in tobacco smokers. Am J Psychiatry 156: 130-132.
40. Gilman SE, Abraham HD (2001). A longitudinal study of the order of onset of alcohol dependence and major depression. Drug Alcohol Depend 63: 277-286.
41. Goldman D, Dean M, Brown GL, Bolos AM, Tokola R, Virkkunen M et al (1992). D2 dopamine receptor genotype and cerebrospinal fluid homovanillic acid, 5-hydroxyindoleacetic acid and 3-methoxy-4-hydroxyphenylglycol in alcoholics in Finland and the United States. Acta Psychiatr Scand 86: 351-357.
42. Grace AA (2000). The tonic/phasic model of dopamine system regulation and its implications for understanding alcohol and psychostimulant craving. Addiction 95(Suppl 2): S119-S128.
43. Grant BF (1997). Prevalence and correlates of alcohol use and DSM-IV alcohol dependence in the United States: results of the national Longitudinal Alcohol Epidemiological Survey. J Stud Alcohol 58: 464-473.
44. Greenfield TK, Weisner C (1995). Drinking problems and self-reported criminal behavior, arrests and convictions: 1990 US alcohol and 1989 county surveys. Addiction 90: 361-373.
45. Gruenberg AM, Goldstein RD (1997). Depressive disorders. In: Tasman A, Kay J, Lieberman JA (eds) Psychiatry, Vol. 2 WB Saunders Co: Philadelphia. pp 990-1019.
46. Hamilton M (1960). A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56-62.
47. Hawley RJ, Schulman E, Major LF, Poplack J, Catravas GN (1988). Elevated cerebrospinal fluid histidine in alcohol withdrawal. Alcohol 5: 321-323.
48. Herz LR, Volicer L, D'Angelo N, Gadish D (1990). Additional psychiatric illness by Diagnostic Interview Schedule in male alcoholics. Compr Psychiatry 31: 72-79.
49. Hesselbrock MN, Meyer RE, Keener JJ (1985). Psychopathology in hospitalized alcoholics. Arch Gen Psychiatry 42: 1050-1055.
50. Hibbeln JR, Linnoila M, Umhau JC, Rawlings R, George DT, Salem Jr N (1998). Essential fatty acids predict metabolites of serotonin and dopamine in cerebrospinal fluid among healthy control subjects, and early- and late-onset alcoholics. Biol Psychiatry 44: 235-242.
51. Houston JP, Maas JW, Bowden CL, Contreras SA, McIntyre KL, Javors MA (1986). Cerebrospinal fluid HVA, central brain atrophy, and clinical state in schizophrenia. Psychiatry Res 19: 207-214.
52. Jones JS, Stanley B, Mann JJ, Frances AJ, Guido JR, Traskman-Bendz L et al (1990). CSF 5-HIAA and HVA concentrations in elderly depressed patients who attempted suicide. Am J Psychiatry 147: 1225-1227.
53. Johnson MR, Lydiard RB, Zealberg JJ, Fossey MD, Ballenger JC (1994). Plasma and CSF HVA levels in panic patients with comorbid social phobia. Biol Psychiatry 36: 425-427.
54. Kaakkola S, Tuomainen P, Mannisto PT, Palo J (1993). Biogenic amine metabolites in the CSF of patients with late onset and alcoholic ataxias. Acta Neurol Scand 87: 309-311.
55. Kanemaru K, Mitani K, Yamanouchi H (1998). Cerebrospinal fluid homovanillic acid levels are not reduced in early corticobasal degeneration. Neurosci Lett 245: 121-122.
56. Kapur S, Mann JJ (1992). Role of the dopaminergic system in depression. Biol Psychiatry 32: 1-17.
57. Kato N, Takahashi S, Tani N, Iwase N, Odani K (1979). Changes in the metabolism of biogenic amines in alcoholism - especially regarding CSF monoamine metabolites and serum DBH activity. Alcohol Clin Exp Res 3: 24-27.
58. Koob GF (1992). Neural mechanisms of drug reinforcement. In: Kalivas PW, Samson HH (eds) The Neurobiology of Drug and Alcohol Addiction. New York Academy of Sciences: New York. pp 171-191.
59. Koslow SH, Maas JW, Bowden CL, Davis JM, Hanin I, Javaid J (1983). CSF and urinary biogenic amines and metabolites in depression and mania. A controlled, univariate analysis. Arch Gen Psychiatry 40: 999-1010.
60. Limson R, Goldman D, Roy A, Lamparski D, Ravitz B, Adinoff B et al (1991). Personality and cerebrospinal fluid monoamine metabolites in alcoholics and controls. Arch Gen Psychiatry 48: 437-441.
61. Lindstrom LH (1985). Low HVA and normal 5HIAA CSF levels in drug-free schizophrenic patients compared to healthy volunteers: correlations to symptomatology and family history. Psychiatry Res 14: 265-273.
62. Lykouras L, Markianos M, Hatzimanolis J, Malliaras D, Stefanis C (1994). Biogenic amine metabolites in delusional (psychotic) depression and melancholia subtypes of major depression. Prog Neuropsychopharmacol Biol Psychiatry 18: 1261-1271.
63. Major LF, Ballenger JC, Goodwin FK, Brown GL (1977). Cerebrospinal fluid homovanillic acid in male alcoholics: effects of disulfiram. Biol Psychiatry 12: 635-642.
64. McGrath PJ, Nunes EV, Quitkin FM (2000). Current concepts in the treatment of depression in alcohol-dependent patients. Psychiatr Clin North Am 23: 695-711.
65. Modell JG, Mountz JM, Glaser FB, Lee JY (1993). Effects of haloperidol on measures of craving and impaired control in alcoholic subjects. Alcohol Clin Exp Res 17: 234-240.
66. Moir ATB, Aschcroft GW, Crawford TBB, Eccleston D, Guldberg HC (1970). Cerebral metabolites in cerebrospinal fluid as a biochemical approach to the brain. Brain 93: 357-368.
67. Murray CJ, Lopez AD (1997). Global mortality, disability, and the contribution of risk factors: global burden of disease study. Lancet 349: 1436-1442.
68. Nelson CR, Stussman BJ (1994). Alcohol- and drug-related visits to hospital emergency departments: 1992 national hospital ambulatory medical care survey. Adv Data 251: 1-16.
69. Nemeroff CB, Musselman DL, Nathan KI, Schatzberg AF, Knable MB, Kllinman JE (1997). Pathophysiological basis of psychiatric disorders: focus on mood disorders and schizophrenia. In: Tasman A, Kay J, Lieberman JA (eds) Psychiatry, Vol. 1 WB Saunders Co: Philadelphia. pp 258-295.
70. Nevo I, Hamon M (1995). Neurotransmitter and neuromodulatory mechanism involved in alcohol abuse and alcoholism. Neurochem Int 26: 305-336.
71. Nicholls P, Edwards G, Kyle E (1974). Alcoholics admitted to four hospitals in England. II. General and cause-specific mortality. QJ Stud Alcohol 35: 841-855.
72. Noble EP (1996). Alcoholism and the dopaminergic system A review. Addict Biol 1: 333-348.
73. Nordin C, Eklundh T, Fernstrom V, Swedin A, Zachau AC (1995). Gradients of CSF monoamine metabolites: a comparison between male and female volunteers. J Psychiatr Res 29: 133-140.
74. Oquendo MA, Mann JJ (2000). The biology of impulsivity and suicidality. Psychiatr Clin North Am 23: 11-25.
75. O'Sullivan K, Rynne C, Miller J, O'Sullivan S, Fitzpatrick V, Hux M et al (1988). A follow-up study on alcoholics with and without co-existing affective disorder. Br J Psychiatry 152: 813-819.
76. Petrakis IL, Trevisan L, D'Souza C, Gil R, Krasnicki S, Webb E et al (1999). CSF monoamine metabolite and beta endorphin levels in recently detoxified alcoholics and healthy controls: prediction of alcohol cue-induced craving? Alcohol Clin Exp Res 23: 1336-1341.
77. Pihl RO, LeMarquand D (1998). Serotonin and aggression and the alcohol-aggression relationship. Alcohol Alcoholism 33: 55-65.
78. Placidi GP, Oquendo MA, Malone KM, Huang YY, Ellis SP, Mann JJ (2001). Aggressivity, suicide attempts, and depression: relationship to cerebrospinal fluid monoamine metabolite levels. Biol Psychiatry 50: 783-791.
79. Post RM, Kotin J, Goodwin FK, Gordon EK (1973). Psychomotor activity and cerebrospinal fluid amine metabolites in affective illness. Am J Psychiatry 130: 67-72.
80. Quarfordt SD, Kalmus GW, Myers RD (1991). Ethanol drinking following 6-OHDA lesions of nucleus accumbens and tuberculum olfactorum of the rat. Alcohol 8: 211-217.
81. Raleigh MJ, Brammer GL, McGuire MT, Pollack DB, Yuwiler A (1992). Individual differences in basal cisternal cerebrospinal fluid 5-HIAA and HVA in monkeys. The effects of gender, age, physical characteristics, and matrilineal influences. Neuropsychopharmacology 7: 295-304.
82. Reddy PL, Khanna S, Subhash MN, Channabasavanna SM, Rao BS (1992). CSF amine metabolites in depression. Biol Psychiatry 31: 112-118.
83. Reuster T, Rilke O, Oehler J (2002). High correlation between salivary MHPG and CSF MHPG. Psychopharmacology 162: 415-418.
84. Robinson TE, Berridge KC (1993). The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Rev 18: 247-291.
85. Roos BE, Silfverskiöld BP (1973). Homovanillic acid in cerebrospinal fluid of alcoholics. N Engl J Med 288: 1358-1359.
86. Roy A, DeJong J, Lamparski D, Adinoff B, George T, Moore V et al (1991b). Mental disorders among alcoholics. Relationship to age of onset and cerebrospinal fluid neuropeptides. Arch Gen Psychiatry 48: 423-427.
87. Roy A, DeJong J, Lamparski D, George T, Linnoila M (1991a). Depression among alcoholics. Relationship to clinical and cerebrospinal fluid variables. Arch Gen Psychiatry 48: 428-432.
88. Roy A, Lamparski D, De Jong J, Adinoff B, Ravitz B, George DT et al (1990). Cerebrospinal fluid monoamine metabolites in alcoholic patients who attempt suicide. Acta Psychiatr Scand 81: 58-61.
89. Roy A, Linnoila M (1989). CSF studies on alcoholism and related behaviours. Prog Neuropsychopharmacol Biol Psychiatry 13: 505-511.
90. Samson HH, Tolliver GA, Schwarz-Stevens K (1990). Oral ethanol self-administration: a behavioral pharmacological approach to SND control mechanisms. Alcohol 7: 187-191.
91. Schatzberg AF, Garlow SL, Nemeroff CB (2002). Molecular and cellular mechanisms of depression. In: Davis KL, Charney D, Coyle JT, Nemeroff C (eds) Neuropsychopharmacology: The Fifth Generation of Progress. Lippincott, Williams & Wilkins: Philadelphia. pp 1039-1050.
92. Scheinin M, Chang WH, Kirk KL, Linnoila M (1983). Simultaneous determination of 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindoleacetic acid, and homovanillic acid in cerebrospinal fluid with high-performance liquid chromatography using electrochemical detection. Anal Biochem 131: 246-253.
93. Schuckit MA (1986). Genetic and clinical implications of alcoholism and affective disorder. Am J Psychiatry 143: 140-147.
94. Seegal RF (1985). Lumbar cerebrospinal fluid homovanillic acid concentrations are higher in female than male non-human primates. Brain Res 334: 375-379.
95. Sharma RP, Javaid JI, Faull K, Davis JM, Janicak PG (1994). CSF and plasma MHPG, and CSF MHPG index: pretreatment levels in diagnostic groups and response to somatic treatments. Psychiatry Res 51: 51-60.
96. Sher KJ, Trull TJ, Bartholow BD, Vieth A (1999). Personality and alcoholism: issues, methods, and etiological processes. In: Leonard KE, Blane HT (eds) Psychological Theories of Drinking and Alcoholism. Guilford Press: New York. pp 54-105.
97. Soderstrom H, Blennow K, Manhem A, Forsman A (2001). CSF studies in violent offenders. I. 5-HIAA as a negative and HVA as a positive predictor of psychopathy. J Neural Transm 108: 869-878.
98. Spak L, Spak F, Allebeck P (2000). Alcoholism and depression in a Swedish female population: co-morbidity and risk factors. Acta Psychiatr Scand 102: 44-51.
99. Spiegel D, King R (1992). Hypnotizability and CSF HVA levels among psychiatric patients. Biol Psychiatry 31: 95-98.
100. Stanley M, Träskman-Bendz L, Dorovini-Zis K (1985). Correlations between aminergic metabolites simultaneously obtained from human CSF and brain. Life Sci 37: 1279-1286.
101. Takahashi S, Yamane H, Kondo H, Tani N, Kato N (1974). CSF monoamine metabolites in alcoholism: a comparative study with depression. Folia Psychiatr Neurol 28: 347-354.
102. Thase ME, Salloum IM, Cornelius JD (2001). Comorbid alcoholism and depression: treatment issues. J Clin Psychiatry 62(Suppl 20): 32-41.
103. Valenzuela CF, Harris RA (1997). Alcohol: neurobiology. In: Lowinson JH, Ruiz P, Millman RB, Langrod JG (eds) Substance Abuse. A Comprehensive Textbook, 3rd edn Williams & Wilkins: Baltimore. pp 119-142.
104. Van Praag HM, Korf J, Lakke JPWF, Schut T (1975). Dopamine metabolism in depressions, psychoses, and Parkinson's disease: the problem of specificity of biological variables in behavior disorders. Psychol Med 5: 138-146.
105. Vavrousek-Jakuba E, Cohen CA, Shoemaker WJ (1992). Ethanol effects of CNS dopamine receptors: in vivo binding following voluntary ethanol intake in rats. In: Naranjo CA, Sellers EM (eds) Novel Pharmacological Interventions for Alcoholism. Springer: New York. pp 372-374.
106. Vestergaard P, Sorensen T, Hoppe E, Rafaelsen OJ, Yates CM, Nicolaou N (1978). Biogenic amine metabolites in cerebrospinal fluid of patients with affective disorders. Acta Psychiatr Scand 58: 88-96.
107. Virkkunen M, Eggert M, Rawlings R, Linnoila M (1996). A prospective follow-up study of alcoholic violent offenders and fire setters. Arch Gen Psychiatry 53: 523-529.
108. Virkkunen M, Rawlings R, Tokola R, Poland RE, Guidotti A, Nemeroff C et al (1994). CSF biochemistries, glucose metabolism, and diurnal activity rhythms in alcoholic, violent offenders, fire setters, and healthy volunteers. Arch Gen Psychiatry 51: 20-27.
109. Weiss F, Koob GF (1991). The neuropharmacology of ethanol self-administration. In: Meyer RE, Koob GF, Lewis MJ, Paul SM (eds) Neuropharmacology of Ethanol. Birkhauser: Boston. pp 125-162.
110. Weiss F, Parsons LH, Schulteis G, Hyytia P, Lorang MT, Bloom FE et al (1996). Ethanol self-administration restores withdrawal-associated deficiencies in accumbal dopamine and 5-hydroxytryptamine release in dependent rats. J Neurosci 16: 3474-3485.
111. Weisbeck GA, Weijers HG, Gross JP (2000). Craving for alcohol and dopamine receptor sensitivity in alcohol-dependent men and coutroe subjects. Neural Transm 107: 691-699.
112. Westenberg HG, Verhoeven WM (1988). CSF monoamine metabolites in patients and controls: support for a bimodal distribution in major affective disorders. Acta Psychiatr Scand 78: 541-549.
113. Zucker RA, Gomberg ESL (1986). Etiology of alcoholism reconsidered: the case for a biopsychosocial process. Am Psychol 41: 783-793.